New heart mapping tool aims to improve treatment for persistent AFib

NCT ID NCT06529978

Recruiting now Disease control Sponsor: CoreMap Inc. Source: ClinicalTrials.gov ↗

First seen Mar 24, 2026 · Last updated Apr 25, 2026 · Updated 4 times

Summary

This study tests a new mapping system (CoreMap) to help doctors treat persistent atrial fibrillation (AFib), a type of irregular heartbeat. About 245 adults with persistent AFib will have a standard ablation procedure guided by this system. The goal is to see if it safely and effectively stops AFib episodes for at least 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

NCH Downtown Baker Hospital
ENROLLING_BY_INVITATION

Naples, Florida, 34102, United States
Na Homolce Hospital
RECRUITING

Praha Klanovice, Czechia
University of Vermont Medical Center
ENROLLING_BY_INVITATION

Burlington, Vermont, 05401, United States

Conditions

Explore the condition pages connected to this study.

PERSISTENT ATRIAL FIBRILLATION